Hypertonic Lactate After Cardiac Arrest
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorErasme University Hospital
About this trial
The study is intended to test the hypothesis that sodium lactate infusion after resuscitation from a cardiac arrest will decrease the magnitude of brain damage, as measured by the serum biomarker concentration of NSE.
Eligibility criteria
Qualifiers
Age > 18 years old
Sustained (> 20 minutes) return of spontaneous circulation (ROSC)
Comatose (GCS < 9)
Time to ROSC > 15'
Disqualifiers
Protected categories (Pregnant women)
Anticipated withdrawal of support within 24 hours
Traumatic cause of cardiac arrest
Body weight at admission > 120Kg
Trial design
Treatments tested in this trial
- Sodium Lactate Solution
Treatment groups
125 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov